We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RVPH market cap is 72.48M. The company's latest EPS is USD -1.7334 and P/E is -5.05.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.56M | -7.78M | -6.74M | -12.07M | -10.71M |
| Net Income | -3.52M | -8.12M | -6.6M | -12.44M | -10.49M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -725k | -2.43M | -10.11M | -24.31M | -39.5M |
| Net Income | 618k | -3.78M | -8.52M | -24.34M | -39.26M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.04M | 18.92M | 12.9M | 11.84M | 5.39M |
| Total Liabilities | 3.68M | 6.61M | 7.12M | 10.22M | 13.91M |
| Total Equity | 20.36M | 12.32M | 5.79M | 1.62M | -8.52M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.02M | 8.76M | 31.4M | 18.92M | 23.7M |
| Total Liabilities | 3.26M | 1.33M | 2.72M | 6.61M | 17.98M |
| Total Equity | 5M | 7.43M | 28.69M | 12.32M | 5.72M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.27M | -18.96M | -7.95M | -13.27M | -19.45M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 7.77M | 7.79M | 687k | 5.9M | 5.9M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -427k | -3.73M | -10.67M | -18.96M | -28.33M |
| Investing | 5.7M | N/A | N/A | N/A | N/A |
| Financing | -5.52M | 12.49M | 31.6M | 7.79M | 33.17M |
| Market Cap | 72.48M |
| Price to Earnings Ratio | -5.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.48 |
| Price to Book Ratio | 34.65 |
| Dividend Yield | - |
| Shares Outstanding | 22.65M |
| Average Volume (1 week) | 102.35k |
| Average Volume (1 Month) | 138.76k |
| 52 Week Change | -55.80% |
| 52 Week High | 9.2499 |
| 52 Week Low | 2.67 |
| Spread (Intraday) | 0.55 (15.94%) |
| Company Name | Reviva Pharmaceuticals Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://revivapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
